| 000 | 01818 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517220145.0 | ||
| 264 | 0 | _c20181119 | |
| 008 | 201811s 0 0 eng d | ||
| 022 | _a1440-1746 | ||
| 024 | 7 |
_a10.1111/jgh.14292 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAuesomwang, Chonticha | |
| 245 | 0 | 0 |
_aTen-day high-dose proton pump inhibitor triple therapy versus sequential therapy for Helicobacter pylori eradication. _h[electronic resource] |
| 260 |
_bJournal of gastroenterology and hepatology _cNov 2018 |
||
| 300 |
_a1822-1828 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAmoxicillin _xadministration & dosage |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aClarithromycin _xadministration & dosage |
| 650 | 0 | 4 |
_aDizziness _xchemically induced |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGastritis _xdrug therapy |
| 650 | 0 | 4 | _aHelicobacter Infections |
| 650 | 0 | 4 | _aHelicobacter pylori |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLansoprazole _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNausea _xchemically induced |
| 650 | 0 | 4 | _aPatient Compliance |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aProton Pump Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aManeerattanaporn, Monthira | |
| 700 | 1 | _aChey, William D | |
| 700 | 1 | _aKiratisin, Pattarachai | |
| 700 | 1 | _aLeelakusolwong, Somchai | |
| 700 | 1 | _aTanwandee, Tawesak | |
| 773 | 0 |
_tJournal of gastroenterology and hepatology _gvol. 33 _gno. 11 _gp. 1822-1828 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/jgh.14292 _zAvailable from publisher's website |
| 999 |
_c28433317 _d28433317 |
||